Consistent with the role of TGFβ and Snail that promotes tumorigenic behaviors, the administration of TGFβ elevated MTT-based viability and scratch-based motility of EO771 mammary tumor cells (Figure S4A,B). This evidence concerns the gene SNAI1 and breast cancer.